Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
from The Boston Globe https://ift.tt/33uRZdO
Andrew Jacobs
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.
https://ift.tt/3xY6Ued May 10, 2021 at 03:24AM
ليست هناك تعليقات:
إرسال تعليق